Institutional Ownership Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP). We have compiled data on the 66 institutions that hold shares in the stock, with a total of 8.11 Million shares, which have been reported (via 13F filing form) to have a value of $17 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bml Capital Management, LLC
Zionsville, IN |
Feb 06, 2025 Q4 2024 |
2,643,907
shares
|
$5.53 Million
3.97% of portfolio
|
Q4 2024
Added 20.94%
|
|
|
Murchinson Ltd.
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
1,750,959
shares
|
$3.66 Million
2.03% of portfolio
|
Q4 2024
Added 2.46%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
845,188
shares
|
$1.77 Million
0.06% of portfolio
|
Q4 2024
Added 2.04%
|
|
|
Morgan Jess S & CO Inc
|
Oct 21, 2022 Q3 2022 |
366,401
shares
|
$765,778
2.07% of portfolio
|
Q3 2022
Added 16.21%
|
|
|
Rathbones Group PLC
Liverpool, X0 |
Feb 13, 2025 Q4 2024 |
289,803
shares
|
$605,688
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
241,400
shares
|
$504,525
0.0% of portfolio
|
Q4 2024
Reduced 5.56%
|
|
|
Peapod Lane Capital LLC
Bedford Hills, NY |
Jan 29, 2025 Q4 2024 |
227,239
shares
|
$474,929
0.55% of portfolio
|
Q4 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
167,653
shares
|
$350,394
0.0% of portfolio
|
Q4 2024
Reduced 2.64%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
151,808
shares
|
$317,278
0.0% of portfolio
|
Q4 2024
Reduced 38.11%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
118,995
shares
|
$248,699
0.0% of portfolio
|
Q4 2024
Added 143.82%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
112,981
shares
|
$236,130
0.0% of portfolio
|
Q4 2024
Added 300.87%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
110,378
shares
|
$230,690
0.0% of portfolio
|
Q4 2024
Reduced 22.1%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
107,062
shares
|
$223,759
0.0% of portfolio
|
Q4 2024
Reduced 4.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
91,027
shares
|
$190,246
0.0% of portfolio
|
Q4 2024
Reduced 32.26%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
89,706
shares
|
$187,485
0.0% of portfolio
|
Q2 2024
Added 0.46%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
85,525
shares
|
$178,747
0.0% of portfolio
|
Q4 2024
Added 1923.3%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
72,489
shares
|
$151,502
0.0% of portfolio
|
Q4 2024
Added 238.7%
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
68,940
shares
|
$144,084
0.01% of portfolio
|
Q1 2023
New holding
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
60,818
shares
|
$127,109
0.0% of portfolio
|
Q4 2024
Added 1.27%
|
|
|
Squarepoint Ops LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
54,439
shares
|
$113,777
0.0% of portfolio
|
Q4 2024
Reduced 34.69%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
49,663
shares
|
$103,795
0.0% of portfolio
|
Q4 2024
Reduced 14.81%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
34,633
shares
|
$72,382
0.0% of portfolio
|
Q4 2024
Reduced 22.44%
|
|
|
Marquette Asset Management, LLC
|
Jan 14, 2025 Q4 2024 |
33,311
shares
|
$69,619
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
Feb 07, 2025 Q4 2024 |
26,200
shares
|
$54,757
0.0% of portfolio
|
Q4 2023
Reduced 3.59%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
25,455
shares
|
$53,200
0.0% of portfolio
|
Q4 2023
Added 21.74%
|